DMAC vs ETR
DiaMedica Therapeutics Inc (DMAC) versus Entergy Corporation (ETR) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Entergy Corporation (ETR) is a utilities - regulated electric company listed on US.
DMAC does not have a complete income-statement cache yet.
Latest reported ETR revenue for 2025-12-31 was $12.95B. Net income was $1.77B. Revenue was up 9.0% from 2024-12-31 to 2025-12-31. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
DMAC currently screens at market cap $157.4M. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
Not investment advice. Open the DMAC and ETR stock pages for the full models.
Not investment advice.